Effects of benzodiazepines, antidepressants and opioids on driving: A systematic review and meta-analysis of epidemiological and experimental evidence

Drug Safety

Volumn 34, Issue 2, 2011, Pages 125-156

  Dassanayake, Tharaka ^a   Michie, Patricia ^a   Carter, Gregory ^b   Jones, Alison ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Antidepressants, adverse reactions; Benzodiazepines, adverse reactions; Driving; Flunitrazepam, adverse reactions serious; Flurazepam, adverse reactions; Lorazepam, adverse reactions; Meta analysis; Nitrazepam, adverse reactions; Opioid analgesics, adverse reactions; Serotonin uptake inhibitors, adverse reactions; Temazepam, adverse reactions; Triazolam, adverse reactions; Tricyclic antidepressants, adverse reactions; Zolpidem, adverse reactions; Zopiclone, adverse reactions.

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOBAZAM; CODEINE; DIAZEPAM; DIHYDROCODEINE; ESZOPICLONE; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MEDAZEPAM; MIDAZOLAM; NITRAZEPAM; OPIATE; SEDATIVE AGENT; TEMAZEPAM; TRAMADOL; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE; ZOPICLONE;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BEDTIME DOSAGE; CAR DRIVING; CASE CONTROL STUDY; COHORT ANALYSIS; DOSE RESPONSE; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EXPOSURE; DRUG HALF LIFE; DRUG URINE LEVEL; DRUG USE; EVENING DOSAGE; HUMAN; MEDICAL RECORD; META ANALYSIS; MORNING DOSAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TRAFFIC ACCIDENT; TRAFFIC SAFETY; TREATMENT DURATION;

ACCIDENTS, TRAFFIC; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; AUTOMOBILE DRIVING; BENZODIAZEPINES; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; RESEARCH DESIGN; RISK FACTORS; RISK-TAKING;

EID: 78751615961     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11539050-000000000-00000     Document Type: Article

References (102)

1. Amado-Boccara I, Gougoulis N, Poirier Littre MF, et al. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 1995; 19 (3): 479-93
2. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005; 66 Suppl. 2: 9-13
3. Thompson PJ. Antidepressants and memory. Hum Psychopharmacol 1991; 6: 79-90
4. Longo MC, Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part II. The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000; 32 (5): 623-32
5. O'Hanlon JF. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 1984; 18 Suppl. 1: 121-9S
6. Hindmarch I, Hanks GW, Hewett AJ. Clobazam, a 1,5- benzodiazepine, and car-driving ability. Br J Clin Pharmacol 1977; 4 (5): 573-8
7. Mercier-Guyon C, Lejay J, Choay P. Comparative study of the effects of captodiamine and lorazepam on car driving ability. Clin Drug Investig 1999; 17 (6): 451-9
8. Iwamoto K, Kawamura Y, Takahashi M, et al. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers. Psychiatry Clin Neurosci 2008; 62 (5): 610-6
9. Linnoila M, Hakkinen S. Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving. Clin Pharmacol Ther 1974 Apr; 15 (4): 368-73
10. Willumeit HP, Ott H, Neubert W. Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short- and long-acting benzodiazepines. Psychopharmacology (Berl) 1984; 1 Suppl.: 182-92
11. Michon JA. A critical view of driver behavior models: what do we know, what should we do? In: Evans L, Schwing RC, editors. Human behavior and traffic safety. New York: Plenum Press, 1985: 485-520
12. Michon JA. Explanatory pitfalls and rule-based driver models. Accid Anal Prev 1989; 21 (4): 341-53
13. van der Molen HH, Botticher AMT. A hierarchical risk model for traffic participants. Ergonomics 1988; 31 (4): 537-55
14. Verster JC, Volkerts ER, Spence DW, et al. Effects of sleep medications on cognition, psychomotor skills, memory and driving performance in the elderly. Curr Psychiatry Rev 2007; 3 (4): 281-92
15. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18 (5): 297-328
16. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 2003; 64 (1): 20-9
17. Bachs LC, Engeland A, Morland JG, et al. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther 2009; 85 (6): 596-9
18. Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9 (8): 818-22
19. Bramness JG, Skurtveit S, Morland J, et al. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007; 39 (5): 1050-5
20. Skegg DC, Richards SM, Doll R. Minor tranquillisers and road accidents. BMJ 1979; 1 (6168): 917-9
21. Honkanen R, Ertama L, Linnoila M. Role of drugs in traffic accidents. BMJ 1980; 281 (6251): 1309-12
22. Jick H, Hunter JR, Dinan BJ, et al. Sedating drugs and automobile accidents leading to hospitalization. Am J Public Health 1981; 71 (12): 1399-400
23. Lagier G. Are benzodiazepines a risk factor for road accidents? Drug Alcohol Depend 1993; 33 (1): 19-22
24. Leveille SG, Buchner DM, Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5 (6): 591-8
25. Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278 (1): 27-31
26. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352 (9137): 1331-6
27. Longo MC, Lokan RJ, White JM. The relationship between blood benzodiazepine concentration and vehicle crash culpability. J Traffic Med 2001; 29 (1-2): 36-43
28. McGwin Jr G, Sims RV, Pulley L, et al. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol 2000; 152 (5): 424-31
29. Mura P, Kintz P, Ludes B, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 2003; 133 (1-2): 79-85
30. Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004; 36 (2): 239-48
31. Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004; 36 (4): 631-6
32. Dubois S, Bedard M, Weaver B. The impact of benzodiazepines on safe driving. Traffic Inj Prev 2008; 9 (5): 404-13
33. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992 Oct 1; 136 (7): 873-83
34. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5 (3): 239-44
35. Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol 1998; 13 Suppl. 2: S115-23
36. Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007; 17 (8): 597-602
37. Bramness JG, Skurtveit S, Neutel CI, et al. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiatry 2008; 69 (7): 1099-103
38. Gibson JE, Hubbard RB, Smith CJP, et al. Use of selfcontrolled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol 2009; 169 (6): 761-8
39. Drummer OH. The role of drugs in road safety. Aust Prescr 2008; 31 (2): 33-5
40. Rapoport MJ, Lanctot KL, Streiner DL, et al. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 2009; 70 (5): 663-73
41. Brunnauer A, Laux G, David I, et al. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. J Clin Psychiatry 2008; 69 (12): 1880-6
42. de Gier JJ, Hart BJ, Nelemans FA, et al. Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology (Berl) 1981; 73 (4): 340-4
43. Menefee LA, Frank ED, Crerand C, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med 2004; 5 (1): 42-9
44. Shen J, Moller HJ, Wang X, et al. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J Clin Psychiatry 2009; 70 (3): 370-7
45. Friedel B, Sjoo S, Reker K, et al. Testing drivers taking diazepam in the Daimler-Benz driving simulator. J Traffic Med 1991; 19 (1): 15-27
46. O'Hanlon JF, Volkerts ER. Hypnotics and actual driving performance. Acta Psychiatr Scand 1986; 74 Suppl. 332: 95-104
47. Schmidt U, Brendemuhl D, Ruther E. Aspects of driving after hypnotic therapy with particular reference to temazepam. Acta Psychiatr Scand 1986; 74 Suppl. 332: 112-8
48. Brookhuis KA, Volkerts ER, O'Hanlon JF. Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol 1990; 39 (1): 83-7
49. Vermeeren A, O'Hanlon JF, Declerck AC, et al. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther 1995; 21 (1): 47-64
50. Partinen M, Hirvonen K, Hublin C, et al. Effects of aftermidnight intake of zolpidem and temazepam on driving ability in women with non-oraganic insomnia. Sleep Med 2003; 4 (6): 553-61
51. Staner L, Ertle S, Boeijinga P, et al. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl) 2005; 181 (4): 790-8
52. Moore NC. Medazepam and the driving ability of anxious patients. Psychopharmacology (Berl) 1977; 52 (1): 103-6
53. van Laar MW, Volkerts ER, van Willigenburg AP. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. J Clin Psychopharmacol 1992; 12 (2): 86-95
54. O'Hanlon JF, Vermeeren A, Uiterwijk MMC, et al. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test: an integration of three studies. Neuropsychobiology 1995; 31 (2): 81-8
55. Veldhuijzen DS, van Wijck AJ, Verster JC, et al. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients. J Psychopharmacol 2006; 20 (6): 782-8
56. Vanakoski J, Mattila MJ, Seppala T. Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects. Eur J Clin Pharmacol 2000; 56 (6-7): 453-8
57. Van Laar MW, Van Willigenburg APP, Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 1995; 15 (1): 30-40
58. Leufkens TRM, Vermeeren A. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. J Clin Psychopharmacol 2009; 29 (5): 432-8
59. Meskali M, Berthelon C, Marie S, et al. Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study. Psychopharmacology (Berl) 2009; 207 (3): 461-7
60. Hindmarch I, Gudgeon AC. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 1980; 10 (2): 145-50
61. Laurell H, Tornros J. The carry-over effects of triazolam compared with nitrazepam and placebo in acute emergency driving situations and in monotonous simulated driving. Acta Pharmacol Toxicol (Copenh) 1986; 58 (3): 182-6
62. Clayton AB, Harvey PG, Betts TA. The effects of two antidepressants, imipramine and viloxazine, upon driving performance. Psychopharmacology (Berl) 1977; 55 (1): 9-12
63. Betts TA, Birtle J. Effect of two hypnotic drugs on actual driving performance next morning. BMJ 1982; 285 (6345): 852
64. Biehl B. Studies of clobazam and car-driving. Br J Clin Pharmacol 1979; 7 Suppl. 1: 85-90S
65. Hindmarch I, Subhan Z. The effects of midazolam in conjunction with alcohol on sleep, psychomotor performance and car driving ability. Int J Clin Pharmacol Res 1983; 3 (5): 323-9
66. Hindmarch I, Subhan Z, Stoker MJ. The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr Scand Suppl 1983; 308: 141-6
67. Ridout F,Hindmarch I. Effects of tianeptine and mianserin on car driving skills. Psychopharmacology (Berl) 2001; 154 (4): 356-61
68. Boyle J, Trick L, Johnsen S, et al. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Hum Psychopharmacol 2008; 23 (5): 385-97
69. Willumeit HP, OttH,Neubert W, et al. Alcohol interaction of lormetazepam, mepindolol sulphate and diazepam measured by performance on the driving simulator. Pharmacopsychiatry 1984; 17 (2): 36-43
70. Volkerts ER, Van LaarMW, VanWilligenburg APP, et al. A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1mg and oxazepam 50 mg. Hum Psychopharmacol 1992; 7 (5): 297-309
71. Kuitunen T. Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs. Pharmacol Toxicol 1994; 75 (2): 91-8
72. Verster JC, Mets MAJ. Psychoactive medication and traffic safety. Int J Environ Res Public Health 6 (3): 1041-54
73. Verster JC, Volkerts ER, Olivier B, et al. Zolpidem and traffic safety: the importance of treatment compliance. Curr Drug Saf 2007; 2 (3): 220-6
74. O'Hanlon JF, Haak TW, Blaauw GJ, et al. Diazepam impairs lateral position control in highway driving. Science 1982; 217 (4554): 79-81
75. Moskowitz H, Smiley A. Effects of chronically administered buspirone and diazepam on driving-related skills performance. J Clin Psychiatry 1982; 43 (12 II): 45-55
76. Van Laar M, Volkerts E, Verbaten M. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers. Psychopharmacology (Berl) 2001; 154 (2): 189-97
77. Verster JC, Volkerts ER, Verbaten MN. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study. Neuropsychopharmacology 2002; 27 (2): 260-9
78. Leufkens TR, Vermeeren A, Smink BE, et al. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1mg. Psychopharmacology (Berl) 2007; 191 (4): 951-9
79. Laurell H, Tornros J. Interaction effects of hypnotics and alcohol on driving performance. J Traffic Med 1991; 19 (1): 9-13
80. Bocca ML, Le Doze F, Etard O, et al. Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology (Berl) 1999; 143 (4): 373-9
81. Leufkens TRM, Lund JS, Vermeeren A. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 2009; 18 (4): 387-96
82. Iudice A, Bonanni E, Maestri M, et al. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers. Int J Clin Pharmacol Ther 2002; 40 (7): 304-9
83. Vermeeren A, Danjou PE, O'Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20mg on memory and actual driving performance. Hum Psychopharmacol 1998; 13 Suppl. 2: S98-107
84. Vermeeren A, Riedel WJ, Van Boxtel MPJ, et al. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 2002; 25 (2): 224-31
85. Matthews A, Kirkby KC, Martin F. The effects of singledose lorazepam on memory and behavioural learning. J Psychopharmacol 2002; 16 (4): 345-54
86. Verster JC, Volkerts ER, Schreuder AH, et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol 2002; 22 (6): 576-83
87. Otmani S, Demazieres A, Staner C, et al. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 2008; 23 (8): 693-705
88. Ramaekers JG, Muntjewerff ND, O'Hanlon JF. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995; 39 (4): 397-404
89. Wingen M, Bothmer J, Langer S, et al. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry 2005; 66 (4): 436-43
90. Veldhuijzen DS, Kenemans JL, Van Wijck AJM, et al. Acute and subchronic effects of amitriptyline on processing capacity in neuropathic pain patients using visual event-related potentials: preliminary findings. Psychopharmacology (Berl) 2006; 183 (4): 462-70
91. Ramaekers JG, Muntjewerff ND, Van Veggel LMA, et al. Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers. Hum Psychopharmacol 1998; 13 Suppl. 2: S87-97
92. Robbe HWJ, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. EurNeuropsychopharmacol 1995; 5 (1): 35-42
93. Iwamoto K, Takahashi M, Nakamura Y, et al. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum Psychopharmacol 2008; 23 (5): 399-407
94. Hindmarch I, Harrison C, Shillingford CA. An investigation of the effects of lofepramine, nomifensine, amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving. Int Clin Psychopharmacol 1988; 3 (2): 157-65
95. Landauer AA, Milner G, Patman J. Alcohol and amitriptyline effects on skills related to driving behavior. Science 1969; 163 (3874): 1467-8
96. Hindmarch I, Subhan Z, Stoker MJ. Comparison of the effects of zimeldine, amitriptyline and placebo on brake reaction time. IRCS Med Sci 1983; 11 (6): 532-3
97. Ramaekers JG, Van Veggel LMA, O'Hanlon JF. A crossstudy comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. Clin Neuropharmacol 1994; 17 Suppl. 1: S9-18
98. O'Hanlon JF, Robbe HW, Vermeeren A, et al. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharmacol 1998; 18 (3): 212-21
99. Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 2006; 22 (5): 499-504
100. Krü ger HP, Kazenwadel J, Vollrath M. Grand rapids effects revisited: accidents, alcohol and risk. International Conference on Alcohol, Drugs and Traffic Safety (T'95); 1995 Aug 13-18; Adelaide
101. Kloeden CN, McLean AJ, Moore VM, et al. Travelling speed and the risk of crash involvement. Adelaide: NHMRC Road Accident Research Unit, University of Adelaide, 1997
102. Ball KK, Roenker DL, Wadley VG, et al. Can high-risk older drivers be identified through performance-based measures in a Department of Motor Vehicles setting? J Am Geriatr Soc 2006; 54 (1): 77-84